We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

1 hedge funds and large institutions have $65K invested in Loxo Oncology, Inc in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 231 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 232 → 1 (-231)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.15B → $65K (-$4.15B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 231

Holders
1
Holders Change
-231
Holders Change %
-99.57%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
231
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$391M
2
BlackRock
BlackRock
New York
-$319M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$296M
4
AC
Aisling Capital
New York
-$286M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$280M
Name Holding Trade Value Shares
Change 		Change in
Stake
SGH
126
Sivik Global Healthcare
Connecticut
– -$1.4M -10,000 Closed
N
127
Nuveen
North Carolina
– -$1.24M -8,831 Closed
CCI
128
Columbus Circle Investors
– -$1.23M -8,776 Closed
MLICM
129
Metropolitan Life Insurance Company (MetLife)
New York
– -$1.21M -8,611 Closed
BG
130
Bellevue Group
Switzerland
– -$1.21M -8,600 Closed
AIM
131
Assured Investment Management
New York
– -$1.2M -8,572 Closed
1832 Asset Management
132
1832 Asset Management
Ontario, Canada
– -$1.19M -8,500 Closed
PA
133
Profund Advisors
Maryland
– -$1.16M -8,299 Closed
MSL
134
Mackay Shields LLC
New York
– -$1.13M -8,096 Closed
KCM
135
Kennedy Capital Management
Missouri
– -$1.13M -8,037 Closed
Los Angeles Capital Management
136
Los Angeles Capital Management
California
– -$1.08M -7,716 Closed
Barclays
137
Barclays
United Kingdom
– -$1.08M -7,699 Closed
SG Americas Securities
138
SG Americas Securities
New York
– -$1.01M -7,220 Closed
LCG
139
Lisanti Capital Growth
New York
– -$931K -6,650 Closed
Royal Bank of Canada
140
Royal Bank of Canada
Ontario, Canada
– -$923K -6,597 Closed
OPPM
141
Opus Point Partners Management
New York
– -$870K -6,210 Closed
TI
142
TT International
United Kingdom
– -$840K -6,000 Closed
TAM
143
Tocqueville Asset Management
New York
– -$804K -5,740 Closed
FAM
144
Fred Alger Management
New York
– -$770K -5,500 Closed
ARTA
145
A.R.T. Advisors
New York
– -$711K -5,073 Closed
UBS Group
146
UBS Group
Switzerland
– -$693K -4,949 Closed
Citadel Advisors
147
Citadel Advisors
Florida
– -$686K -4,902 Closed
Stifel Financial
148
Stifel Financial
Missouri
– -$686K -4,889 Closed
DCM
149
Dupont Capital Management
Delaware
– -$674K -4,814 Closed
SBH
150
Segall Bryant & Hamill
Illinois
– -$629K -4,493 Closed
4 5
6
7 8

LOXO Hedge Fund Activity: Q1 2019 in Review

1 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q1 2019, worth a combined $65K — down 100% from $4.15B a quarter earlier.

Sellers outnumbered buyers: 231 funds closed out of LOXO and 0 opened new positions — a net loss of 231 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $391M sold.

  • 1 institutional investor held Loxo Oncology, Inc (LOXO) as of Q1 2019, down from 232 in Q4 2018.
  • Funds reported $65K of Loxo Oncology, Inc stock for Q1 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Loxo Oncology, Inc positions in Q1 2019 and 231 closed out, a net change of -231 holders.
  • The largest Loxo Oncology, Inc seller in Q1 2019 was Vanguard Group, an estimated $391M sold.

Based on aggregated 13F filings for Q1 2019.